10th Drug Discovery Strategic Summit

October 27th– 28th, 2022, San Francisco, USA  

Redefining Your Conference Experience with Excellence!

About The Event

Recent market trends showed that the majority of Drug Discovery operations are outsourced by pharmaceuticals companies to help pace up the projects. Harmonizing our vision of redefining your conference experience. Agile Falcon Strategic Group is bringing the 10th Drug Discovery Strategic Summit (DDSS)’ on October 27th & 28th 2022, in San Fransico, USA. The main focus of the events would revolve around identification, synthesis, artificial intelligence (AI) & machine learning and drug development for therapeutic applications.

Main Focus of The Event

Growing The Industry

Industry Thought Leaders Discussing the Challenges of the Market.

Connecting The People

A See-Suite only, designed to help you make connections that matters.

“I would definitely recommend your interesting summit to other people specially people working in small and mid-size companies. I would say that quality of summit was very good because, we had very interesting talks with all the delegates we met. Same goes for prequalified one-to-one meetings protocol.”

Astorgues Xerrs

Preclinical Project Manager of Afr Oncology

Our Exclusive Meeting Protocol Guarantees a Higher Chance of Cutting the Deal on Spot!

Audience Stats at 10th DDSS

Key Talks You Shouldn’t Miss

Meet the world’s leading drug discovery, development and data analytics experts and thought leaders Leaders in San Francisco.

Igor Nasonkin

Chief Scientific Officer at Phythera Therapeutics

Valery Polyakov

Director, Head of Computational Chemistry at Sutro Biopharma

Majid Ghoddusi

Senior Director, Clinical Biomarkers at Poseida Therapeutics

Lakshman Annamalai

Director of Pathology at Denali Therapeutics

Erik J. Verner

SVP of Research at Angel Pharmaceuticals

Hariprasad Vankayalapati

Chief Scientific Officer Biolexis Therapeutics

Jennifer Johnston

Cofounder and CEO at NysnoBio

George Tetz

CEO at CLS Therapeutics

Anka G. Ehrhardt

Director, Cell-Based Sciences at Merck

Margaret K. Offermann

President and Chief Executive Officer at OncoSpherix

Chulhee Choi

Founder, Chairman & CEO at ILIAS Biologics

Frank Kruse

Vice President, Marketing & Business Development at Sekisui XenoTech

Kok- Seong (KS) Lim

Senior Director, Analytical Sciences at Metagenomi

William Donaldson

President and CEO at Estrigenix Therapeutics

Russ Teichert

Founder and CEO at Scientillant Bioscience

Adiba Ishaque Zanghi

Director Process Development Upstream at Vaxart

Andrea Small-Howard

President & CSO at GB Sciences

Daniel Haders

Co-Founder, CEO at Model Medicines

David M Jackson

CEO at Ceria Therapeutics

Octavian Bucur

Co-Founder at Viron Therapeutics

Bradlee Heckmann

Co-founder & CSO at Asha Therapeutics

Platinum Sponsors

Gold Sponsors

Bronze Sponsors

Our venue
Event Headlines

Our aim is to deliver personalized, integrated and measurable conferences that address the unique requirements and goals of our clients. Agile Falcon (AF) Strategic Group conferences get the right requirement to the right audience at the right time.

Keynote Presentations

100+ Attendees

Panel Discussions

One-to-One Meetings

What Our Clients Say About us

Take our word for it, or hear what your peers have to say about us

Subscribe to Our Newsletter

Don't miss new updates on your email